News Releases

Proton Therapy Coming to Kansas City

KANSAS CITY, Kan - The University of Kansas Health System has reached another major milestone in bringing proton therapy to Kansas City. Proton therapy is an advanced form of targeted radiation treatment that uses protons instead of X-rays to attack...

The University of Kansas Cancer Center Among the First to Offer CAR T-cell Therapy to Treat Multiple Myeloma

Study Analyzes Clinical, Economic Impact of Hemorrhagic Cystitis in Stem Cell Transplant Patients

The results of the study were published in the journal Transplantation and Cell Therapy.

$4.2 Million Grant Awarded for Breast Cancer Chemoprevention Study

Researchers at KU Cancer Center have received a grant from the NCI to study the effects of bazedoxifene and low-dose conjugated estrogen in women.

Project ECHO Seeks to Improve Breast Cancer Disparities

A $100,000 grant from Susan G. Komen Kansas + Western Missouri will support The University of Kansas Cancer Center’s efforts to improve breast cancer disparities in the region.

Commemorating the 50th Anniversary of the National Cancer Act

The NCI and its designated cancer centers will share stories of the National Cancer Act’s impact on cancer throughout 2021.

Study to Examine Androgen Deprivation Therapy Use in African American Men

Prostate cancer is fueled by androgens, which include testosterone and other hormones. ADT lowers androgen to castrate levels, and it is the standard of care for advanced and metastatic prostate cancer.

Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer

OVERLAND PARK, KAN. – The Women’s Cancer Center at The University of Kansas Cancer Center now offers intraoperative radiation therapy, or IORT, for early-stage breast cancer patients who are treated with lumpectomy. We are the first and only cancer c...

Cancer Center Joins Leading Cancer Organizations to Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You

KU Cancer Center part of nationwide effort to resume appropriate cancer screening and treatment to prevent excess deaths.

Grant to Advance Metastatic Breast Cancer Research

Danny Welch, PhD, researcher and associate director for Education at The University of Kansas Cancer Center, has been awarded a $100,000 grant from METAvivor.

Cancer Center Members Named to National Breast Cancer Clinical Trials Task Force

Jamie Wagner, DO, FACOS, FACS, division chief, breast surgical oncology, and Shane Stecklein, MD, PhD, radiation oncologist, have been appointed to the Breast Oncology Local Disease (BOLD) Task Force of the National Cancer Institute (NCI) Breast Cancer Steering Committee (BCSC).

Tobacco Treatment Training Program Earns Elite Accreditation

The University of Kansas Tobacco Treatment Specialist training program has been accredited by the Council for Tobacco Treatment Training Programs, joining just 23 other such accredited programs in the world.

Study Identifies New Therapy Option for Metastatic Breast Cancer

A targeted therapy approved for the treatment of metastatic triple-negative breast cancer may also be effective in the treatment of hormone receptor-positive, HER2-negative breast cancer that has metastasized. Priyanka Sharma, MD, breast medical onco...

Cancer Center is a contributor to 49 research studies at the 62nd American Society of Hematology Annual Meeting

Researchers from The University of Kansas Cancer Center are involved in the presentation of nearly 50 research studies at the 62nd American Society of Hematology (ASH) Annual Meeting, to be held virtually Dec. 5-8 because of the COVID-19 pandemic.

Are E-cigarettes Safer Than Cigarettes? Study Sheds Light on the Issue

Scientists and medical professionals have long debated whether e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.